Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > About to KABOOM on both US and Canada sides

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Apr 19, 2023 4:16pm

129 Views

Post# 35403801

RE:RE:RE:RE:About to KABOOM on both US and Canada sides

CA ... Nothing to do with differences of opinions. Only about the toxic attitude of lazy armchair quarterbacks that only whine on our investment without making any efforts to share anything else than negativity, day after day.

<< Previous

Bullboard Posts

Next >>

Arctic Wolf to acquire BlackBerry’s Cylance endpoint security assets